Overview

Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate safety, tolerability and pharmacokinetics of sitaxentan following single and multiple oral administrations of sitaxentan sodium in Japanese healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Sitaxsentan